ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,556 | +236.2% | 5,879 | +280.8% | 0.00% | +300.0% |
| Q2 2023 | $47,463 | -40.9% | 1,544 | -30.8% | 0.00% | -50.0% |
| Q1 2023 | $80,347 | +282.9% | 2,230 | +320.0% | 0.00% | +100.0% |
| Q4 2022 | $20,985 | -8.8% | 531 | -6.8% | 0.00% | 0.0% |
| Q3 2022 | $23,000 | +27.8% | 570 | +29.8% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | -33.3% | 439 | -36.2% | 0.00% | 0.0% |
| Q1 2022 | $27,000 | +50.0% | 688 | +53.9% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | +500.0% | 447 | +538.6% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 70 | +34.6% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 52 | +10.6% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 47 | +261.5% | 0.00% | – |
| Q4 2020 | $1,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |